BOSTON SCIENTIFIC - MAPLE GROVE
Manufacturer adverse-event records for BOSTON SCIENTIFIC - MAPLE GROVE come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2004–2018 · heavy-book · elevated Death-code · balanced
Death-code intensity
BOSTON SCIENTIFIC - MAPLE GROVE carries an elevated Death-code share
Death-coded event_type rows are 1,025 of 26,804 (3.82% · elevated tercile among 443 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for BOSTON SCIENTIFIC - MAPLE GROVE
The standout signal for BOSTON SCIENTIFIC - MAPLE GROVE is Death-code intensity: 3.82% of 26,804 reports (elevated tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BOSTON SCIENTIFIC - MAPLE GROVE with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Malfunction at 17,820 (66.5% of event_type total). Peak single-year volume reaches 4,088 reports across 13 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.